Supplemental Methods

PB CD34 testing
Duplicate aliquots containing 0.5 x 10 6 mononuclear cells were incubated with anti-CD45 FITC (fluorescein isothiocyanate, BD#340664), anti-CD34 PE (phycoerythrin, Beckman Coulter #IM 1871) monoclonal antibodies at room temperature in the dark for 20 minutes. Red blood cells were lysed with fixative-free ammonium chloride (10x NH 4 CL Lysing Solution, Beckman Coulter #IM 3514) diluted with reagent grade water to 1x. 7-amino-actinomycin D (7AAD) (Beckman Coulter 3IM3422) was then added. Samples were mixed, kept at room temperature in the dark for 15 minutes and then stored for <1 hr on wet ice in the dark until acquisition/ analysis. With analysis, compensations were set to avoid spectral overlap for CD34 PE and 7AAD; 7AAD versus FSC plots were used to define non-debris regions examined in subsequent dot plots.
Similarly, the FL1 secondary threshold was adjusted on the CD45 FITC versus SSC dot plot to exclude red cells, platelets, and other debris but not any CD45 FITC cells. The sequential Boolean gating strategy defined by ISHAGE was then applied to identify CD34+ cells. Viability was then evaluated on the FSC versus 7AAD dot plot instead of the traditional SSC vs 7AAD plots as this technique avoids overestimation of percent viability which can sometimes be seen with traditional gating strategies. Absolute CD34+ cell numbers were calculated using the two platform method with total white blood cell counts measured on an Advia 2120 hematology analyzer (Siemens Healthcare, Germany) 
